Clinical Trial Update: Comparison of Two Combinations in Antiretroviral Post-Exposure Prophylaxis for HIV-1: Tenofovir/Emtricitabine (Truvada ®) + Lopinavir/Ritonavir (Kaletra ®) vs Tenofovir/Emtricitabine/Cobicistat/Elvitegravir (Stribild ®). Prospective, Randomized, Open. [Phase 4]

View source ↗

Summary

Prospective, randomized Phase 4 trial comparing two HIV-1 post-exposure prophylaxis regimens: Tenofovir/Emtricitabine plus Lopinavir/Ritonavir versus Tenofovir/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)
• Stribild (elvitegravir; cobicistat; emtricitabine; tenofovir disoproxil fumarate)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Fundacion Clinic per a la Recerca Biomédica | Conditions: HIV | Phase 4 | Status: COMPLETED